🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
SMM
$SMMT
🔒 US EquitiesSummit Therapeutics Inc
AVG HISTORICAL GAP
-5.16%
MAX GAP RECORD
-25.35%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $SMMT
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$SMMT
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 27, 2026 Earnings Release 2026-10-27 (AFTER CLOSE (21:00)) |
-0.91%
|
| Jul 23, 2026 Earnings Release 2026-07-23 (AFTER CLOSE) |
-8.41%
|
| Apr 30, 2026 Earnings Release 2026-04-30 (AFTER CLOSE) |
-25.35%
|
| Feb 23, 2026 Earnings Release 2026-02-23 (AFTER CLOSE) |
-1.93%
|
| Oct 20, 2025 Earnings Release 2025-10-20 (BEFORE OPEN) |
-10.20%
|
| Aug 11, 2025 Earnings Release 2025-08-11 (AFTER CLOSE) |
-4.23%
|
| Apr 30, 2025 Earnings Release 2025-04-30 (AFTER CLOSE) |
+1.08%
|
| Feb 24, 2025 Earnings Release 2025-02-24 (UNDETERMINED) |
+0.00%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
5.9%
Bullish Gaps (2)
Bearish Gaps (6)
Neutral / Flat (2)
📖 Intelligence Summary
Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗